You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 260 No. 19, November 18, 1988 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorials
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Aggressive War on Acute Myocardial Infarction: Is the Blitzkrieg Strategy Changing?

Melvin D. Cheitlin, MD

JAMA. 1988;260(19):2894-2896.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Evolution in the treatment of patients with acute myocardial infarction has taken us, within a brief period of less than 40 years, from impotent observation to aggressive invasive intervention designed to open suddenly occluded coronary arteries. The attack on the patient with acute myocardial infarction, requiring sophisticated catheterization facilities and personnel immediately available at all times, takes on many of the attributes of battlefield evacuation, complete with helicopters and pseudo-MASH units. The concept that led to this approach was the resuscitation of the idea that thrombus over a plaque was the most important mechanism of sudden obstruction in transmural myocardial infarction. Chazov et al1 in the Soviet Union were the first to demonstrate fibrinolysis by intracoronary streptokinase. Rentrop et al2 stimulated general interest in intracoronary thrombolysis. Later, Schroder et al3 demonstrated that the occluded coronary artery could be opened by intravenous streptokinase.

The first randomized, controlled study . . . [Full Text PDF of this Article]


Author Affiliations

University of California, San Francisco San Francisco General Hospital



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1988 American Medical Association. All Rights Reserved.